• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤衍生突变型 p53 的致癌性可通过招募 PLK3 得到增强。

The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3.

机构信息

Philips Institute, Virginia Commonwealth University, Richmond, VA, 23298, USA.

Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, 23298, USA.

出版信息

Nat Commun. 2021 Jan 29;12(1):704. doi: 10.1038/s41467-021-20928-8.

DOI:10.1038/s41467-021-20928-8
PMID:33514736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7846773/
Abstract

p53 mutations with single amino acid changes in cancer often lead to dominant oncogenic changes. Here, we have developed a mouse model of gain-of-function (GOF) p53-driven lung cancer utilizing conditionally active LSL p53-R172H and LSL K-Ras-G12D knock-in alleles that can be activated by Cre in lung club cells. Mutation of the p53 transactivation domain (TAD) (p53-L25Q/W26S/R172H) eliminating significant transactivation activity resulted in loss of tumorigenicity, demonstrating that transactivation mediated by or dependent on TAD is required for oncogenicity by GOF p53. GOF p53 TAD mutations significantly reduce phosphorylation of nearby p53 serine 20 (S20), which is a target for PLK3 phosphorylation. Knocking out PLK3 attenuated S20 phosphorylation along with transactivation and oncogenicity by GOF p53, indicating that GOF p53 exploits PLK3 to trigger its transactivation capability and exert oncogenic functions. Our data show a mechanistic involvement of PLK3 in mutant p53 pathway of oncogenesis.

摘要

癌症中 p53 点突变导致单一氨基酸改变,常导致显性致癌变化。在这里,我们利用条件性激活的 LSL p53-R172H 和 LSL K-Ras-G12D 敲入等位基因,在肺 club 细胞中利用 Cre 激活,开发了一种 p53 驱动的肺癌获得性功能(GOF)的小鼠模型。p53 转录激活域(TAD)(p53-L25Q/W26S/R172H)突变消除了显著的转录激活活性,导致肿瘤发生能力丧失,表明 GOF p53 的致癌性需要 TAD 介导或依赖的转录激活。GOF p53 TAD 突变显著降低了附近 p53 丝氨酸 20(S20)的磷酸化,S20 是 PLK3 磷酸化的靶点。敲除 PLK3 减弱了 GOF p53 的 S20 磷酸化、转录激活和致癌性,表明 GOF p53 利用 PLK3 触发其转录激活能力并发挥致癌功能。我们的数据表明,PLK3 参与了突变型 p53 致癌途径的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/4e23126dc3aa/41467_2021_20928_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/50a0bc262693/41467_2021_20928_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/82078799e928/41467_2021_20928_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/4184aea5e036/41467_2021_20928_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/7139a63bca15/41467_2021_20928_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/37b77d8b989b/41467_2021_20928_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/601b6db40a4c/41467_2021_20928_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/65ab81bc01a6/41467_2021_20928_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/52a2099ada28/41467_2021_20928_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/4e23126dc3aa/41467_2021_20928_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/50a0bc262693/41467_2021_20928_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/82078799e928/41467_2021_20928_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/4184aea5e036/41467_2021_20928_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/7139a63bca15/41467_2021_20928_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/37b77d8b989b/41467_2021_20928_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/601b6db40a4c/41467_2021_20928_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/65ab81bc01a6/41467_2021_20928_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/52a2099ada28/41467_2021_20928_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57e/7846773/4e23126dc3aa/41467_2021_20928_Fig9_HTML.jpg

相似文献

1
The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3.肿瘤衍生突变型 p53 的致癌性可通过招募 PLK3 得到增强。
Nat Commun. 2021 Jan 29;12(1):704. doi: 10.1038/s41467-021-20928-8.
2
Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells.功能获得性p53激活多种信号通路以诱导肺癌细胞发生致癌性。
Mol Oncol. 2017 Jun;11(6):696-711. doi: 10.1002/1878-0261.12068. Epub 2017 May 8.
3
Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter.通过与p53反式激活结构域和启动子的多次接触,表皮生长因子受体的上调促进了肺癌细胞对功能获得性p53的成瘾。
Oncotarget. 2016 Mar 15;7(11):12426-46. doi: 10.18632/oncotarget.6998.
4
Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.功能获得性突变 p53 通过靶向转录因子 FOXO3a 和 FOXM1 促进头颈部鳞状细胞癌细胞的致癌潜能。
Oncogene. 2018 Mar;37(10):1279-1292. doi: 10.1038/s41388-017-0032-z. Epub 2017 Dec 22.
5
p53 gain-of-function mutations increase Cdc7-dependent replication initiation.p53 获得性功能突变增加了 Cdc7 依赖性的复制起始。
EMBO Rep. 2017 Nov;18(11):2030-2050. doi: 10.15252/embr.201643347. Epub 2017 Sep 8.
6
Allele specific gain-of-function activity of p53 mutants in lung cancer cells.肺癌细胞中 p53 突变体的等位基因特异性获得性功能。
Biochem Biophys Res Commun. 2012 Nov 9;428(1):6-10. doi: 10.1016/j.bbrc.2012.09.029. Epub 2012 Sep 16.
7
Reactive oxygen species-induced phosphorylation of p53 on serine 20 is mediated in part by polo-like kinase-3.活性氧诱导的p53丝氨酸20位点磷酸化部分由polo样激酶3介导。
J Biol Chem. 2001 Sep 28;276(39):36194-9. doi: 10.1074/jbc.M104157200. Epub 2001 Jul 10.
8
Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.功能获得性 p53 突变体上调 CXC 趋化因子并增强细胞迁移。
Carcinogenesis. 2012 Feb;33(2):442-51. doi: 10.1093/carcin/bgr270. Epub 2011 Nov 22.
9
Mutant p53 oncogenicity: dominant-negative or gain-of-function?突变型 p53 致癌性:显性负效应还是获得性功能?
Carcinogenesis. 2020 Dec 31;41(12):1635-1647. doi: 10.1093/carcin/bgaa117.
10
Identification and characterization of the binding sequences and target genes of p53 lacking the 1st transactivation domain.缺乏第一个转录激活结构域的 p53 的结合序列和靶基因的鉴定与特征分析。
Cancer Sci. 2020 Feb;111(2):451-466. doi: 10.1111/cas.14279. Epub 2020 Jan 13.

引用本文的文献

1
Oncogenic p53 induces mitotic errors in lung cancer cells by recopying DNA replication forks conferring targetable proliferation advantage.致癌性p53通过复制赋予可靶向增殖优势的DNA复制叉,在肺癌细胞中诱导有丝分裂错误。
Res Sq. 2025 Aug 13:rs.3.rs-7303237. doi: 10.21203/rs.3.rs-7303237/v1.
2
HER2; p53 Co-mutated Cancers Show Increased Histone Acetylation and are Sensitive to Neratinib plus Trastuzumab Deruxtecan.HER2;p53共突变癌症显示组蛋白乙酰化增加,并且对奈拉替尼加曲妥珠单抗德鲁昔单抗敏感。
bioRxiv. 2025 Jul 10:2025.07.06.663368. doi: 10.1101/2025.07.06.663368.
3
Comprehensive analysis reveals PLK3 as a promising immune target and prognostic indicator in glioma.

本文引用的文献

1
DNA replication in progenitor cells and epithelial regeneration after lung injury requires the oncoprotein MDM2.祖细胞中的 DNA 复制和肺损伤后的上皮细胞再生需要癌蛋白 MDM2。
JCI Insight. 2019 Oct 17;4(20):128194. doi: 10.1172/jci.insight.128194.
2
A dominant-negative effect drives selection of missense mutations in myeloid malignancies.显性负效应驱动髓系恶性肿瘤中错义突变的选择。
Science. 2019 Aug 9;365(6453):599-604. doi: 10.1126/science.aax3649.
3
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
综合分析表明,PLK3是胶质瘤中一个有前景的免疫靶点和预后指标。
Oncol Res. 2025 Jan 16;33(2):431-442. doi: 10.32604/or.2024.050794. eCollection 2025.
4
PLK3 weakens antioxidant defense and inhibits proliferation of porcine Leydig cells under oxidative stress.在氧化应激条件下,PLK3会削弱抗氧化防御能力并抑制猪睾丸间质细胞的增殖。
Sci Rep. 2025 Jan 21;15(1):2612. doi: 10.1038/s41598-025-86867-2.
5
Myrtenol ameliorates inflammatory, oxidative, apoptotic, and hyperplasic effects of urethane-induced atypical adenomatous hyperplasia in the rat lung.桃金娘烯醇可改善乌拉坦诱导的大鼠肺非典型腺瘤样增生的炎症、氧化、凋亡和增生效应。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1785-1797. doi: 10.1007/s00210-024-03375-2. Epub 2024 Aug 23.
6
High PLK3 levels are linked with less tumor invasion, lower FIGO stage and better prognosis of endometrial cancer.PLK3 水平高与肿瘤侵袭性低、FIGO 分期低和子宫内膜癌预后较好有关。
Biomark Med. 2024;18(10-12):523-533. doi: 10.1080/17520363.2024.2347192. Epub 2024 May 24.
7
p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications.肺癌中的p53基因学与生物学:见解、影响及临床应用
Biomedicines. 2024 Jun 29;12(7):1453. doi: 10.3390/biomedicines12071453.
8
PLK3 is linked with higher tumor stage and unfavorable prognosis in patients with colorectal cancer.PLK3 与结直肠癌患者的较高肿瘤分期和不良预后相关。
Biomark Med. 2024;18(6):221-230. doi: 10.2217/bmm-2023-0591. Epub 2024 Apr 17.
9
Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study.从海洋天然产物库中鉴定 PLK1-PBD 抑制剂:3D QSAR 药效团、ADMET、骨架跃迁、分子对接和分子动力学研究。
Mar Drugs. 2024 Feb 10;22(2):83. doi: 10.3390/md22020083.
10
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.癌症中靶向p53信号通路:分子机制与临床研究
MedComm (2020). 2023 May 28;4(3):e288. doi: 10.1002/mco2.288. eCollection 2023 Jun.
癌症基因组图谱中 TP53 基因与通路改变的综合分析。
Cell Rep. 2019 Jul 30;28(5):1370-1384.e5. doi: 10.1016/j.celrep.2019.07.001.
4
Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation.突变型和野生型肿瘤抑制因子p53诱导p300自身乙酰化。
iScience. 2018 Jun 29;4:260-272. doi: 10.1016/j.isci.2018.06.002. Epub 2018 Jun 7.
5
Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion.抑癌基因 p53 功能获得性突变的治疗性消融可抑制 Stat3 介导的结直肠癌肿瘤生长和侵袭。
Cancer Cell. 2018 Aug 13;34(2):298-314.e7. doi: 10.1016/j.ccell.2018.07.004.
6
Mutant p53 partners in crime.突变型 p53 狼狈为奸。
Cell Death Differ. 2018 Jan;25(1):161-168. doi: 10.1038/cdd.2017.185. Epub 2017 Nov 3.
7
The Mediator Complex: At the Nexus of RNA Polymerase II Transcription.中介体复合物:RNA 聚合酶 II 转录的交汇点
Trends Cell Biol. 2017 Oct;27(10):765-783. doi: 10.1016/j.tcb.2017.07.001. Epub 2017 Aug 1.
8
Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells.功能获得性p53激活多种信号通路以诱导肺癌细胞发生致癌性。
Mol Oncol. 2017 Jun;11(6):696-711. doi: 10.1002/1878-0261.12068. Epub 2017 May 8.
9
Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication.突变型p53通过促进异常复制建立可靶向的肿瘤依赖性。
J Clin Invest. 2017 May 1;127(5):1839-1855. doi: 10.1172/JCI87724. Epub 2017 Apr 10.
10
Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.野生型和癌症相关突变型p53的转录调控
Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):a026054. doi: 10.1101/cshperspect.a026054.